← Back to Clinical Trials
Recruiting NCT05874141
NCT05874141 Comorbidities in Type 2 Diabetes Mellitus
◆ AI Clinical Summary
Plain-language summary for patients
| NCT ID | NCT05874141 |
| Status | Recruiting |
| Phase | — |
| Sponsor | New Valley University |
| Condition | Type 2 Diabetes |
| Study Type | INTERVENTIONAL |
| Enrollment | 288 participants |
| Start Date | 2023-11-15 |
| Primary Completion | 2025-12-30 |
Trial Parameters
Condition Type 2 Diabetes
Sponsor New Valley University
Study Type INTERVENTIONAL
Phase N/A
Enrollment 288
Sex ALL
Min Age 18 Years
Max Age 90 Years
Start Date 2023-11-15
Completion 2025-12-30
Interventions
HBA1CLipid profile, including total, LDL, and HDL cholesterol and TriglyceridesUrine analysis and urinary albumin-to-creatinine ratio
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
Brief Summary
Type 2 diabetes mellitus (DM) has adopted a top priority as it is a disease with an increasing prevalence. The number of people living with DM has increased more than fourfold over the past 40 years to more than 460 million people today
Eligibility Criteria
Inclusion Criteria: * Patients with type 2 diabetes. Exclusion Criteria: 1. Patients with type 1 diabetes. 2. Patients with secondary diabetes.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology